Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.36% | 1.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.36% | 1.20% | |||
| Cost of Revenue | -16.01% | -0.20% | |||
| Gross Profit | 1.34% | 1.59% | |||
| SG&A Expenses | -5.52% | 2.11% | |||
| Depreciation & Amortization | -3.43% | -0.49% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.13% | 1.60% | |||
| Operating Income | 22.73% | -2.93% | |||
| Income Before Tax | 22.43% | -18.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.43% | -19.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.43% | -19.74% | |||
| EBIT | 22.73% | -2.93% | |||
| EBITDA | 26.70% | -3.73% | |||
| EPS Basic | 22.56% | -19.63% | |||
| Normalized Basic EPS | 22.95% | -18.45% | |||
| EPS Diluted | 22.56% | -19.63% | |||
| Normalized Diluted EPS | 29.51% | -31.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 10.34% | -9.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
